Welcome : Guest

Urinary Incontinence Drugs

Abstract

This report presents Insights into the Urinary Incontinence Drugs Market. Illustrated with 10 data tables, the report comprises of a brief statistical summarization of the global market including North America, Europe, and US. Also included are global competitive player market shares.

Code: MT-00206
Price: $495
Report Type: Market Trends & Insights
Pages: 14
Date: June 2016
Market Data Tables: 10

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Urinary Incontinence Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......4
Table 2: Urology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties......5
Table 3: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis/Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......6
Table 4: Prevalence of Urinary Incontinence by Gender in the US (2015) - Percentage Share Breakdown for Men and Women......7
Table 5: Prevalence of Urinary Incontinence in Women (Age Group (18-44)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......8
Table 6: Prevalence of Urinary Incontinence in Women (Age Group (>60)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......9
Table 7: Urinary Incontinence Drugs Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......10
Table 8: Prevalence of Overactive Bladder (OAB) in Women (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......11
Table 9: Prevalence of Overactive Bladder (OAB) in Men (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......12
Table 10: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......13